Zymeworks (ZYME) Retained Earnings (2021 - 2026)

Zymeworks has reported Retained Earnings for 6 years, with the latest figure at -$6.6 million in Q1 2026.

• Quarterly Retained Earnings fell 2.48% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.6 million (down 2.48% YoY) and the FY2025 annual result came in at -$6.1 million, up 99.27% from the prior year.
• Retained Earnings eased to -$6.6 million in Q1 2026 per ZYME's latest filing, from -$6.1 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$5.9 million in Q1 2023 and troughed at -$868.2 million in Q3 2022.
• A 5-year average of -$291.7 million and a median of -$7.7 million in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 8291.09% in 2022, then surged 99.27% in 2025.
• Over 5 years, Retained Earnings stood at -$558.8 million in 2022, then fell by 21.24% to -$677.4 million in 2023, then slipped by 22.57% to -$830.3 million in 2024, then soared by 99.27% to -$6.1 million in 2025, then dropped by 7.99% to -$6.6 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$6.6 million, -$6.1 million, and -$6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.